North America Resuscitation Devices Market Outlook (2022-2033)

Expansion of emergency medical services (EMS) and ambulance networks

There is a lot of growth happening in the resuscitation devices market in North America due to the expansion and development of EMS and ambulance systems. In the US, in cities like Los Angeles and Chicago, there are more ambulances, and in suburban areas, there is an installation of satellite EMS stations due to population growth. All these factors lead to an increase in the use of defibrillators, automatic cardiopulmonary resuscitators, and portable kits for emergency resuscitation.

On the other hand, there is a definite trend toward providing the ambulances with the equipment to provide advanced life support rather than basic life transportation. In the United States, many EMS agencies run fleets of vehicles in which the majority have paramedics who are trained in cardiac resuscitation and have real-time monitoring systems installed. As a result, there is an increasing demand for small and durable resuscitation equipment which can function efficiently under such circumstances.

Geographic factors also play an important role in the development of EMS programs in Canada. The provinces with a sparse population base are focusing on the expansion of air ambulance systems which will be integrated into ground EMS systems. Such a program calls for efficient and battery-operated resuscitation equipment that can work successfully in such difficult circumstances. Both the countries will continue to develop better and faster emergency response programs, thus demanding better technological advancement in resuscitation equipment.

Expansion of Resuscitation Training Programs and Simulation-Based Education

The growth in North America resuscitation devices market is additionally bolstered due to the increasing preference of institutions toward structured training programs and medical simulation-based training for healthcare professionals. Healthcare institutions throughout North America are increasingly investing in simulation centers that simulate cardiac arrest scenarios, which provide healthcare professionals an opportunity to practice resuscitation procedures utilizing devices like defibrillator, CPR training device, and airway adjuncts.

In the U.S., it is mandatory for medical practitioners, paramedics, and other individuals working in sectors like aviation to undergo mandatory training under programs like advanced cardiac life support (ACLS) and basic life support (BLS). Simulation centers that have sophisticated features, which include high fidelity manikins, are being used for training healthcare professionals regarding the use of various resuscitation devices.

This is evident in Canada where the training of paramedics has been given much importance along with continuing education for professionals. Simulated learning has been incorporated in the curriculum for paramedics and nurses, especially that of resuscitation teamwork. Community CPR and AED training programs are also being implemented to train laypersons in resuscitation skills. As training becomes more advanced and technologically based, there is an increasing need for new resuscitation equipment in North America.

The "North America Resuscitation Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• North America resuscitation devices market size and forecast at regional and country levels for all market segments covered under the scope
• North America resuscitation devices market trends, as well as drivers, restraints, and opportunities
• North America resuscitation devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America Resuscitation devices market
• Detailed company profiles, including SWOT analysis

The geographical scope of the North America resuscitation devices market report is divided into: The US, Canada, and Mexico. The US held the largest share in 2025.

The U.S. dominats in terms of the North America resuscitation devices market owing to its well-developed infrastructure of emergency medicine, the presence of institutions and facilities providing advanced medical care, and high levels of participation of people in saving lives. Most American hospitals are equipped with modern resuscitation technology, which includes automated external defibrillators with monitoring devices, mechanical CPR machines, and intelligent resuscitation devices allowing for receiving information regarding their effectiveness. The most prominent characteristic of the American market is connected to the wide spread of AEDs throughout various public locations due to legislative acts and community-driven efforts promoting their use to increase the chances of quick reaction to any cardiac arrest. In addition, first responders are provided with modern resuscitation equipment to enable quick action before transporting patients to hospitals. Innovation and research also become significant, with ongoing improvements made in device design, connectivity, and ease of use. Training initiatives like simulation training and compulsory CPR training in certain professions become more prevalent to bolster usage of the devices. In addition to the collaboration of health professionals, regulatory authorities, and device manufacturers, such elements ensure that the United States leads the market for resuscitation devices in North America.

• The report includes qualitative and quantitative data in the North America resuscitation devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the North America Resuscitation devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the North America resuscitation devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the North America resuscitation devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover North America resuscitation devices market segments by product type, usage type, application, patient type, end user, and geography across the US, Canada, and Mexico. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the North America resuscitation devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The North America resuscitation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the North America Resuscitation devices market are:

• In September 2025, ZOLL Medical Corporation announced that it received U.S. FDA approval for its Zenix monitor/defibrillator, an advanced resuscitation device featuring real-time CPR and ventilation feedback, and subsequently made it available across the U.S. and Canada.
• In October 2023, Medtronic plc announced that it received U.S. FDA approval for its Aurora EV-ICD system, a novel extravascular implantable defibrillator designed to treat life-threatening arrhythmias while reducing complications associated with traditional transvenous leads, with initial commercialization in the United States.